Domov › Rakovina prostaty › Connecticut
Klinické štúdie Rakovina prostaty v štáte Connecticut
27 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v štáte Connecticut.
Mestá v štáte Connecticut
Oficiálny text štúdie (anglicky)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Yale Cancer Center, New Haven
Prebieha náborFáza 1/2
Vek 12 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT04585750Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Stamford Hospital/Bennett Cancer Center, Stamford
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06632977A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- Yale Cancer Center, New Haven
Prebieha náborFáza 2
Vek 18 a viac · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06172478Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Yale University, New Haven
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 25. 9. 2026 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0064), New Haven
Prebieha náborFáza 3
Vek 18 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT06136650Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Hartford Hospital, Hartford
Prebieha náborFáza 2/3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- Hartford HealthCare Cancer Institute at Hartford Hospital, Hartford
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 22. 9. 2026 · NCT07213674A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer
- GSK Investigational Site, New Haven
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 18. 9. 2026 · NCT06990880High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
- VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 17. 9. 2026 · NCT05011383A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0050), New Haven
- Veterans Affairs Connecticut Healthcare System ( Site 0062), West Haven
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 17. 9. 2026 · NCT06925737The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
- Yale Cancer Center, New Haven
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 14. 9. 2026 · NCT06111781A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
- Yale Cancer Center, New Haven
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 8. 9. 2026 · NCT05800665A Single-arm, Multicenter Prospective Study to Evaluate the Diagnostic Performance of PROSTest in Men With PSA ≥ 3ng/ml Using Biopsy as the Sole Ground Truth
- Wren Laboratories, Branford
Prebieha náborObservačná štúdia
Vek 45 až 80 · Muži · Aktualizované 21. 8. 2026 · NCT07454603Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Yale New Haven Hospital, New Haven
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 21. 8. 2026 · NCT04221542A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- New Haven Hospital - Yale Cancer Center, New Haven
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 17. 8. 2026 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Yale University School of Medicine, New Haven
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 8. 2026 · NCT05919264Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Yale New Haven Hospital, New Haven
Prebieha náborFáza 1
Vek 18 až 100 · Muži · Aktualizované 13. 8. 2026 · NCT05519449A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
- Hartford Healthcare Alliance (Data collection only), Hartford
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 30. 7. 2026 · NCT05751434Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Veterans Affairs Connecticut Healthcare System-West Haven Campus, West Haven
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 14. 7. 2026 · NCT06592924Integrated Cancer Repository for Cancer Research
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
Vek 19 až 110 · Všetky pohlavia · Aktualizované 29. 6. 2026 · NCT02012699A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
- Yale University (Data Collection Only), New Haven
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 25. 6. 2026 · NCT06457919Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Hartford Hospital, Hartford
Prebieha náborFáza 4
Vek 18 až 100 · Muži · Aktualizované 4. 6. 2026 · NCT05803941International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- Yale University, New Haven
Prebieha náborObservačná štúdia
Vek 21 a viac · Muži · Aktualizované 22. 5. 2026 · NCT03151629A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- Yale University, Yale Cancer Center, New Haven
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 3. 2026 · NCT06395519Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
- Smilow Cancer Hospital-Derby Care Center, Derby
- Smilow Cancer Hospital Care Center-Fairfield, Fairfield
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury
- a 11 ďalších
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 29. 1. 2026 · NCT05806515SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Hartford
- Massive Bio SYNERGY-AI site, Norwalk
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Smilow Cancer Hospital Care Center - Guilford, Guilford
- Yale University, New Haven
- Stamford Hospital/Bennett Cancer Center, Stamford
- a 3 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 11. 9. 2025 · NCT03678025Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.